Managing COVID‐19 in patients with inflammatory bowel disease: navigating unprecedented challenges

The COVID‐19 pandemic has demanded a rapid adaptation in healthcare provision, including patients with inflammatory bowel disease (IBD). This viewpoint discusses some of the unique challenges in managing comorbid IBD and COVID‐10 experienced by our team at The Royal Melbourne Hospital, which was at...

Full description

Saved in:
Bibliographic Details
Published in:Internal Medicine Journal 2021-02, Vol.51 (2), p.284-287
Main Authors: Prentice, Ralley E., Al‐Ani, Aysha, Christensen, Britt
Format: Article
Language:English
Subjects:
Australia
COVID-19
COVID-19 - complications
COVID-19 - therapy
Delivery of Health Care
Humans
immunosuppression
Inflammatory bowel disease
Inflammatory bowel diseases
Inflammatory Bowel Diseases - complications
Inflammatory Bowel Diseases - therapy
Intestine
Pandemics
Personal Viewpoint
Personal Viewpoints
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The COVID‐19 pandemic has demanded a rapid adaptation in healthcare provision, including patients with inflammatory bowel disease (IBD). This viewpoint discusses some of the unique challenges in managing comorbid IBD and COVID‐10 experienced by our team at The Royal Melbourne Hospital, which was at the epicentre of the COVID‐19 ‘second‐wave’ surge in Melbourne.
ISSN:1444-0903
1445-5994
1445-5994
DOI:10.1111/imj.15190